As per DelveInsight’s assessment, the Next Generation Sequencing Market is expected to grow at an immense pace in the coming years owing to the The increasing prevalence of pandemic such as COVID-19, Pre- and post-operation and some few of the other applications where Next Generation Sequencing have been used, which is expected to drive the demand for Next Generation Sequencing in the upcoming years.

DelveInsight’s “Next Generation Sequencing Market” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers.  The report also covers the major emerging products and key Next Generation Sequencing companies actively working in the market.

Next Generation Sequencing Overview

RNA or DNA sequences can be found using Next-Generation Sequencing, a massively parallel process that can reveal genetic variation linked to diseases or other biological events. Because of the technology’s scalability, high throughput, and speed, labs may execute a broad range of applications.

Next Generation Sequencing Market Insights

The need for Next-Generation Sequencing is primarily being driven by the increase in infectious disease cases, including the COVID-19 pandemic. Further factors anticipated to boost the global Next-Generation Sequencing market include the development of technology, the rising incidence of cancer worldwide, and the speed at which Next-Generation Sequencing product approvals occur.

DelveInsight Analysis: The Global Next Generation Sequencing market size is anticipated to reach ~USD 26.30 billion by 2028 with a growing CAGR of 18.96% during the forecasted period (2023-2028).

To know more about why North America is leading the market growth in the Next Generation Sequencing market, get a snapshot of the report Next Generation Sequencing Market Trends

https://www.delveinsight.com/report-store/next-generation-sequencing-market

Recent Developments in the Next Generation Sequencing Market Report

• In December 2021, Roche launched the AVENIO Edge System to simplify and automate next-generation sequencing sample preparation, reduce human error and advance precision medicine.
• In May 2021, Illumina, Inc. and Next-Generation Genomics Co., Ltd. launched VeriSeq™ NIPT Solution v2 in Thailand, a CE-IVD, next-generation sequencing (NGS)-based approach to noninvasive prenatal testing (NIPT).
• In February 2021, INOVIO and QIAGEN expanded collaboration to develop next-generation sequencing (NGS) companion diagnostic for INOVIO’s VGX-3100 for advanced cervical dysplasia.

To read more about the latest highlights related to Next Generation Sequencing, get a snapshot of the key highlights entailed in the Next Generation Sequencing Market Forecast Report

Key Players in the Next Generation Sequencing Market

Some of the key market players operating in the Next Generation Sequencing market include- Agilent Technologies, Inc., Illumina Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, QIAGEN, Thermo Fisher Scientific, PerkinElmer Inc., MedGenome, BGI, Pacific Biosciences, GENEWIZ, Oxford Nanopore Technologies plc., Psomagen, Inc., 10x Genomics, Takara Bio Inc., Zymo Research Corporation., NuGEN Technologies, Inc. (Tecan Trading AG), Vela Diagnostics, CD Genomics., HTG Molecular Diagnostics, Inc., and others.

COVID-19 Impact Analysis on the Next Generation Sequencing Market

During the projected period of 2023–2028, North America is anticipated to hold a significant proportion of the global market for Next-Generation Sequencing. The increasing number of infectious disease cases in the area is the cause of this dominance. Furthermore, the region’s whole next-generation sequencing market is anticipated to be driven by a number of factors, including the rise in new cancer cases, the presence of major industry players and top national clinical laboratories, and advantageous reimbursement policies for NGS technology.

Additionally, The market for next-generation sequencing has benefited from the extraordinary COVID-19 epidemic. This is due to the fact that NGS technology, which employs a single-step RNA extraction and offers great scalability and accuracy when compared to the gold-standard RT-qPCR, provides an affordable molecular test for the diagnosis of COVID19. Additionally, during the pandemic crisis, the number of emergency use authorizations (EUAs) for Next-Generation Sequencing tests for SARS-CoV-2 has increased, which has contributed to market growth. So, during the projected period, the market for Next Generation Sequencing is anticipated to continue expanding (2023-2028).

Scope of the Next Generation Sequencing Market Report

• Coverage: Global
• Study Period: 2020–2028
• Next Generation Sequencing Market Segmentation By Product Type: Instruments, Reagents & Consumables And Services), By Sequencing Type (Whole-Genome Sequencing, Whole-Exome Sequencing, Rna Sequencing, Targeted Sequencing, De-Novo Sequencing, Others
• Next Generation Sequencing Market Segmentation By Application Type: Diagnostic, Drug Discovery, Agriculture & Animal Research, Others
• Next Generation Sequencing Market Segmentation By End User: Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Academic & Research Institute
• Next Generation Sequencing Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Next Generation Sequencing Companies: Agilent Technologies, Inc., Illumina Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, QIAGEN, Thermo Fisher Scientific, PerkinElmer Inc., MedGenome, BGI, Pacific Biosciences, GENEWIZ, Oxford Nanopore Technologies plc., Psomagen, Inc., 10x Genomics, Takara Bio Inc., Zymo Research Corporation., NuGEN Technologies, Inc. (Tecan Trading AG), Vela Diagnostics, CD Genomics., HTG Molecular Diagnostics, Inc., and others
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the Next Generation Sequencing market are set to emerge as the trendsetter explore @ Next Generation Sequencing Manufacturer

Table of Contents 

Interested in knowing how the Next Generation Sequencing market will grow by 2028? Click to get a snapshot of the Next Generation Sequencing Market Analysis

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.  

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email: Send Email
Phone: 8774225362
Address:27 Drydock Ave S. Jones Blvd #2432
City: Boston
State: MA
Country: United States
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services